Posaconazole in Dogs

Posaconazole is a prescription antifungal medication your vet may use for dogs with serious fungal infections. It is not FDA-approved specifically for veterinary use, so it is generally prescribed extra-label from human products, which is common in veterinary medicine when a drug is appropriate for a pet’s condition. In dogs, it is most often considered when a fungal infection is widespread, hard to control, or not responding well to more commonly used antifungals such as itraconazole or fluconazole.

This medication has activity against a broad range of fungi and may be part of treatment plans for infections such as aspergillosis, coccidioidomycosis, and histoplasmosis. Fungal infections in dogs often require months of treatment, repeat exams, and lab monitoring. That means the best plan is not only about which drug is chosen, but also what your dog can tolerate, what follow-up is realistic, and what cost range fits your household.

Posaconazole is usually reserved for selected cases rather than routine first-line use. Your vet may recommend it when culture results, imaging findings, prior treatment response, or disease severity suggest a need for a broader-spectrum antifungal. In some dogs, it is used alone. In others, it may be combined with other therapies or supportive care depending on where the infection is located and how sick the dog is.

Because fungal disease can affect the lungs, nose, bones, eyes, brain, skin, or multiple organs, dogs taking posaconazole need individualized care. Your vet will decide whether this medication is appropriate, how long treatment should continue, and what monitoring is needed along the way.

Posaconazole belongs to the triazole class of antifungal medications. Like other azoles, it works by interfering with fungal cell membrane production. More specifically, it blocks an enzyme fungi need to make ergosterol, which is an important part of the fungal cell membrane. Without enough ergosterol, fungal cells cannot function normally or reproduce effectively.

That mechanism does not kill every fungus in exactly the same way, and response can vary by organism, infection site, and how advanced the disease is. In practical terms, posaconazole is valued because it has broad antifungal activity and can be useful in infections that are difficult to manage. Your vet may consider it when a dog has a deep or systemic fungal infection, especially if other azoles have not worked well enough or are not well tolerated.

How the drug is given also matters. Merck Veterinary Manual notes that bioavailability increases when posaconazole is taken with food. That can make administration details important, especially in dogs that are nauseated, have poor appetite, or need compounded formulations. Different formulations do not behave exactly the same, so your vet may choose a suspension or delayed-release tablet based on your dog’s size, diagnosis, and treatment goals.

Treatment success depends on more than the medication alone. Fungal burden, immune status, organ involvement, and how early treatment starts all affect outcome. Even when posaconazole is the right option, improvement may be gradual, and your vet may use exams, bloodwork, imaging, or repeat fungal testing to judge progress over time.

The most common side effects expected with azole antifungals in dogs are digestive upset and appetite changes. A dog taking posaconazole may develop vomiting, diarrhea, reduced appetite, or general stomach upset. Some dogs do well when the medication is given with food, but you should follow your vet’s instructions because the exact formulation matters.

Liver effects are an important concern with azole antifungals. Merck notes that treatment with imidazoles can increase liver-related lab values such as ALT, AST, and bilirubin, which is why your vet may recommend baseline and repeat bloodwork during treatment. Call your vet promptly if your dog becomes very tired, stops eating, vomits repeatedly, develops yellowing of the eyes or gums, or seems to worsen after starting the medication.

A less common but notable adverse effect reported in dogs is neuronal phospholipidosis associated with posaconazole use. That is not something a pet parent can diagnose at home, but it reinforces why this medication should be used thoughtfully and monitored closely, especially during long treatment courses. Dogs with pre-existing liver disease or dogs taking multiple medications may need even closer follow-up.

Side effects do not always mean the drug must be stopped, but they do mean your vet should reassess the plan. Sometimes the answer is dose adjustment, a formulation change, added supportive care, or switching to a different antifungal. The safest next step depends on your dog’s infection, lab results, and overall stability.

Posaconazole dosing in dogs is individualized by your vet. Merck Veterinary Manual lists 5 mg/kg by mouth every 12 hours for dogs, and also notes that oral suspension often requires twice-daily dosing while delayed-release tablets may allow different schedules because of a longer half-life in dogs. Merck also notes a dosage of 10 mg/kg/day has been used in coccidioidomycosis and histoplasmosis. That means there is not one universal schedule for every dog or every formulation.

This is a medication where formulation matters a great deal. Posaconazole is available as an oral suspension and as delayed-release tablets. These products are not always interchangeable on a milligram-for-milligram basis in real-world veterinary use. Your vet will choose the product and schedule based on your dog’s weight, diagnosis, appetite, and whether accurate small dosing is needed.

Food can improve absorption, so your vet may recommend giving the medication with a meal. If your dog vomits after dosing, refuses food, or has trouble swallowing tablets, let your vet know before making changes on your own. Compounded versions may be considered in some cases, but your vet should guide that decision because consistency and absorption are important with antifungal therapy.

Do not stop posaconazole early because your dog seems better. Fungal infections often improve slowly, and treatment may continue for weeks to months after symptoms begin to improve. Missed doses, early discontinuation, or switching formulations without guidance can make treatment less effective.

Posaconazole can interact with other medications because azole antifungals affect drug metabolism and transport. Merck notes that azoles inhibit the metabolism of many drugs and may also compete at P-glycoprotein transport pathways, which can raise concentrations of other medications. This is especially important in dogs already taking drugs with narrow safety margins or medicines that are processed heavily by the liver.

Absorption can also be affected by other medications. Merck notes that absorption of imidazoles other than fluconazole may be reduced by cimetidine, ranitidine, anticholinergic drugs, or gastric antacids. In practice, that means your vet should know about every prescription, over-the-counter product, supplement, probiotic, and stomach medication your dog receives.

Because azoles can increase liver stress, combinations with other potentially hepatotoxic drugs deserve extra caution. Your vet may recommend bloodwork more often if your dog is taking seizure medications, chemotherapy drugs, long-term pain medications, immunosuppressants, or multiple antifungals. The exact risk depends on the full medication list and your dog’s health history.

Never start, stop, or space medications differently without checking with your vet. If another clinic prescribes something new while your dog is on posaconazole, tell them your dog is taking an azole antifungal so they can review for interactions before treatment changes are made.